- Home
- Publications
- Publication Search
- Publication Details
Title
Emerging Role of Noncoding RNAs in EGFR TKI-Resistant Lung Cancer
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 18, Pages 4423
Publisher
MDPI AG
Online
2022-09-13
DOI
10.3390/cancers14184423
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2022
- (2022) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Glioblastoma mutations alter EGFR dimer structure to prevent ligand bias
- (2022) Chun Hu et al. NATURE
- Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics
- (2022) Takayuki Nojima et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Hsa_circ_0001666 promotes non-small cell lung cancer migration and invasion through miR-1184/miR-548I/AGO1 axis
- (2022) Xueting Wang et al. Molecular Therapy-Oncolytics
- The Multi-Omics Analysis of Key Genes Regulating EGFR-TKI Resistance, Immune Infiltration, SCLC Transformation in EGFR-Mutant NSCLC
- (2022) Zhi Wang et al. Journal of Inflammation Research
- Loss of KMT5C Promotes EGFR Inhibitor Resistance in NSCLC via LINC01510-Mediated Upregulation of MET
- (2022) Arpita S. Pal et al. CANCER RESEARCH
- M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma
- (2022) Ashuai Du et al. Molecular Cancer
- Characterization of distinct circular RNA signatures in solid tumors
- (2022) Chengdi Wang et al. Molecular Cancer
- Circular RNA circ-PLCD1 functions as a tumor suppressor in non-small cell lung cancer by inactivation of PI3K/AKT signaling pathway
- (2022) Jiming Si et al. Human Cell
- CircVAPA promotes small cell lung cancer progression by modulating the miR-377-3p and miR-494-3p/IGF1R/AKT axis
- (2022) Jinghan Hua et al. Molecular Cancer
- CircRNAs in lung cancer- role and clinical application
- (2022) Jingwei Li et al. CANCER LETTERS
- LNCcation: lncRNA localization and function
- (2021) Mary Catherine Bridges et al. JOURNAL OF CELL BIOLOGY
- Exosomes-transmitted miR-7 reverses gefitinib resistance by targeting YAP in non-small-cell lung cancer
- (2021) Rui Chen et al. PHARMACOLOGICAL RESEARCH
- circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity
- (2021) Botai Li et al. Nature Communications
- NCCN Guidelines Insights: Non–Small Cell Lung Cancer, Version 2.2021
- (2021) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR–STAT3 signalling
- (2021) Xinya Gao et al. NATURE CELL BIOLOGY
- LncRNA APCDD1L-AS1 induces icotinib resistance by inhibition of EGFR autophagic degradation via the miR-1322/miR-1972/miR-324-3p-SIRT5 axis in lung adenocarcinoma
- (2021) Jie Wu et al. Biomarker Research
- Extracellular Vesicle miR-200c Enhances Gefitinib Sensitivity in Heterogeneous EGFR-Mutant NSCLC
- (2021) Chien-Chung Lin et al. Biomedicines
- Tumor-derived exosomal circRNA_102481 contributes to EGFR-TKIs resistance via the miR-30a-5p/ROR1 axis in non-small cell lung cancer
- (2021) Bo Yang et al. Aging-US
- miR-1/133a and miR-206/133b clusters overcome HGF induced gefitinib resistance in non-small cell lung cancers with EGFR sensitive mutations
- (2021) Demin Jiao et al. JOURNAL OF DRUG TARGETING
- Elevated exosome-derived miRNAs predict osimertinib resistance in non-small cell lung cancer
- (2021) Xinying Li et al. Cancer Cell International
- EGFR in Cancer: Signaling Mechanisms, Drugs, and Acquired Resistance
- (2021) Mary Luz Uribe et al. Cancers
- Identification of Differentially Expressed Circular RNAs as miRNA Sponges in Lung Adenocarcinoma
- (2021) Yuechao Liu et al. Journal of Oncology
- Inhibition of miR-185-3p Confers Erlotinib Resistance Through Upregulation of PFKL/MET in Lung Cancers
- (2021) Ke Li et al. Frontiers in Cell and Developmental Biology
- AL355338 acts as an oncogenic lncRNA by interacting with protein ENO1 to regulate EGFR/AKT pathway in NSCLC
- (2021) Qian Hua et al. Cancer Cell International
- A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosis
- (2021) Tingting Wang et al. CANCER LETTERS
- Oncogenic circRNA C190 Promotes Non–Small Cell Lung Cancer via Modulation of the EGFR/ERK Pathway
- (2021) Afeez Adekunle Ishola et al. CANCER RESEARCH
- Hsa_circ_0005576 promotes osimertinib resistance through the miR‐512‐5p/IGF1R axis in lung adenocarcinoma cells
- (2021) Suo Liu et al. CANCER SCIENCE
- Cell Behavior of Non-Small Cell Lung Cancer Is at EGFR and MicroRNAs Hands
- (2021) Sarah Sayed Hassanein et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- ciRS-7 is a prognostic biomarker and potential gene therapy target for renal cell carcinoma
- (2021) Weipu Mao et al. Molecular Cancer
- The emerging roles of circRNAs in cancer and oncology
- (2021) Lasse S. Kristensen et al. Nature Reviews Clinical Oncology
- Exosomes transmit T790M mutation‐induced resistance in EGFR‐mutant NSCLC by activating PI3K/AKT signalling pathway
- (2020) Xiaozhen Liu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- lncRNA CCAT1 Acts as a MicroRNA-218 Sponge to Increase Gefitinib Resistance in NSCLC by Targeting HOXA1
- (2020) Xiang Jin et al. Molecular Therapy-Nucleic Acids
- LncRNA H19 downregulation confers erlotinib resistance through upregulation of PKM2 and phosphorylation of AKT in EGFR-mutant lung cancers
- (2020) Chen Chen et al. CANCER LETTERS
- Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis
- (2020) Xiaofeng Guo et al. Molecular Cancer
- The expanding regulatory mechanisms and cellular functions of circular RNAs
- (2020) Ling-Ling Chen NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The miR‑625‑3p/AXL axis induces non‑T790M acquired resistance to EGFR‑TKI via activation of the TGF‑β/Smad pathway and EMT in EGFR‑mutant non‑small cell lung cancer
- (2020) Wenwen Du et al. ONCOLOGY REPORTS
- Novel insights into the interplay between m6A modification and noncoding RNAs in cancer
- (2020) You-Cai Yi et al. Molecular Cancer
- LncRNA SNHG15 regulates EGFR-TKI acquired resistance in lung adenocarcinoma through sponging miR-451 to upregulate MDR-1
- (2020) Jiayuan Huang et al. Cell Death & Disease
- Multiple low dose therapy as an effective strategy to treat EGFR inhibitor-resistant NSCLC tumours
- (2020) João M. Fernandes Neto et al. Nature Communications
- HOTAIR induces EGFR-TKIs resistance in non-small cell lung cancer through epithelial-mesenchymal transition
- (2020) Qi Wang et al. LUNG CANCER
- Long non-coding RNA CASC9 promotes gefitinib resistance in NSCLC by epigenetic repression of DUSP1
- (2020) Zhenyao Chen et al. Cell Death & Disease
- Downregulation of miR-506-3p Facilitates EGFR-TKI Resistance through Induction of Sonic Hedgehog Signaling in Non-Small-Cell Lung Cancer Cell Lines
- (2020) Inamul Haque et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- LncRNA SOX2‐OT regulates AKT/ERK and SOX2/GLI‐1 expression, hinders therapy, and worsens clinical prognosis in malignant lung diseases
- (2020) Abril Marcela Herrera‐Solorio et al. Molecular Oncology
- Global miRNA to miRNA Interactions: Impacts for miR-21
- (2020) Meredith Hill et al. TRENDS IN CELL BIOLOGY
- Cucurbitacin mediated regulation of deregulated oncogenic signaling cascades and non-coding RNAs in different cancers: Spotlight on JAK/STAT, Wnt/β-catenin, mTOR, TRAIL-mediated pathways
- (2020) Xiukun Lin et al. SEMINARS IN CANCER BIOLOGY
- The current state and future directions of RNAi-based therapeutics
- (2019) Ryan L. Setten et al. NATURE REVIEWS DRUG DISCOVERY
- Trans ‐3,5,4´‐trimethoxystilbene reduced gefitinib resistance in NSCLC s via suppressing MAPK /Akt/Bcl‐2 pathway by upregulation of miR‐345 and miR‐498
- (2019) Min Lu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The Landscape of Circular RNA in Cancer
- (2019) Josh N. Vo et al. CELL
- FGFR1 Cooperates with EGFR in Lung Cancer Oncogenesis, and Their Combined Inhibition Shows Improved Efficacy
- (2019) Alvaro Quintanal-Villalonga et al. Journal of Thoracic Oncology
- Knockout of lncRNA UCA1 inhibits drug resistance to gefitinib via targeting STAT3 signaling in NSCLC
- (2019) Biyuan Zhang et al. MINERVA MEDICA
- Circular RNA F-circSR derived from SLC34A2-ROS1 fusion gene promotes cell migration in non-small cell lung cancer
- (2019) Ke Wu et al. Molecular Cancer
- Circular RNA circHIPK3 modulates autophagy via MIR124-3p-STAT3-PRKAA/AMPKα signaling in STK11 mutant lung cancer
- (2019) Xiuyuan Chen et al. Autophagy
- NOTCH3 Overexpression and Posttranscriptional Regulation by miR-150 Were Associated With EGFR‐TKI Resistance in Lung Adenocarcinoma
- (2019) Youwei Zhang et al. ONCOLOGY RESEARCH
- PI3K/Akt/mTOR inhibitors in cancer: At the bench and bedside
- (2019) Ali S. Alzahrani SEMINARS IN CANCER BIOLOGY
- Reciprocal regulation of miR‐206 and IL‐6/STAT3 pathway mediates IL6‐induced gefitinib resistance in EGFR‐mutant lung cancer cells
- (2019) Yanhua Yang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Knockdown of lncRNA BLACAT1 reverses the resistance of afatinib to non-small cell lung cancer via modulating STAT3 signalling
- (2019) Degui Shu et al. JOURNAL OF DRUG TARGETING
- RNA-Seq profiling of circular RNA in human lung adenocarcinoma and squamous cell carcinoma
- (2019) Chengdi Wang et al. Molecular Cancer
- Reciprocal regulatory mechanism between miR-214-3p and FGFR1 in FGFR1-amplified lung cancer
- (2019) Ying Yang et al. Oncogenesis
- The Role of Non-coding RNAs in Oncology
- (2019) Frank J. Slack et al. CELL
- Clinical importance of long non‑coding RNA LINC00460 expression in EGFR‑mutant lung adenocarcinoma
- (2019) Yuta Nakano et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- LncRNA UCA1 promotes gefitinib resistance as a ceRNA to target FOSL2 by sponging miR-143 in non-small cell lung cancer
- (2019) Xiliu Chen et al. Molecular Therapy-Nucleic Acids
- Long Noncoding RNA LINC01116 Contributes to Gefitinib Resistance in Non-small Cell Lung Cancer through Regulating IFI44
- (2019) He Wang et al. Molecular Therapy-Nucleic Acids
- Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors
- (2018) D Westover et al. ANNALS OF ONCOLOGY
- Functional Classification and Experimental Dissection of Long Noncoding RNAs
- (2018) Florian Kopp et al. CELL
- The lncRNA RHPN1-AS1 downregulation promotes gefitinib resistance by targeting miR-299-3p/TNFSF12 pathway in NSCLC
- (2018) Xuehao Li et al. CELL CYCLE
- miR‐205 mediates adaptive resistance to MET inhibition via ERRFI1 targeting and raised EGFR signaling
- (2018) Cristina Migliore et al. EMBO Molecular Medicine
- MicroRNA
- (2018) Thomas X. Lu et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- miR-1-3p and miR-206 sensitizes HGF-induced gefitinib-resistant human lung cancer cells through inhibition of c-Met signalling and EMT
- (2018) Demin Jiao et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- TNF-driven adaptive response mediates resistance to EGFR inhibition in lung cancer
- (2018) Ke Gong et al. JOURNAL OF CLINICAL INVESTIGATION
- The role of HGF-MET pathway and CCDC66 cirRNA expression in EGFR resistance and epithelial-to-mesenchymal transition of lung adenocarcinoma cells
- (2018) Nithila A. Joseph et al. Journal of Hematology & Oncology
- MiR-16 regulates the pro-tumorigenic potential of lung fibroblasts through the inhibition of HGF production in an FGFR-1- and MEK1-dependent manner
- (2018) Francesca Andriani et al. Journal of Hematology & Oncology
- High cripto-1 and low miR-205 expression levels as prognostic markers in early stage non-small cell lung cancer
- (2018) Kang-Seo Park et al. LUNG CANCER
- miR-19b enhances proliferation and apoptosis resistance via the EGFR signaling pathway by targeting PP2A and BIM in non-small cell lung cancer
- (2018) Ulrich Baumgartner et al. Molecular Cancer
- PTEN/PTENP1: ‘Regulating the regulator of RTK-dependent PI3K/Akt signalling’, new targets for cancer therapy
- (2018) Nahal Haddadi et al. Molecular Cancer
- Third generation EGFR TKIs: current data and future directions
- (2018) Chee-Seng Tan et al. Molecular Cancer
- Epigenetic silencing of miR-483-3p promotes acquired gefitinib resistance and EMT in EGFR-mutant NSCLC by targeting integrin β3
- (2018) Jinnan Yue et al. ONCOGENE
- A low microRNA-630 expression confers resistance to tyrosine kinase inhibitors in EGFR-mutated lung adenocarcinomas via miR-630/YAP1/ERK feedback loop
- (2018) De-Wei Wu et al. Theranostics
- Increased expression of miR-641 contributes to erlotinib resistance in non-small-cell lung cancer cells by targeting NF1
- (2018) Juan Chen et al. Cancer Medicine
- CiRS-7 promotes growth and metastasis of esophageal squamous cell carcinoma via regulation of miR-7/HOXB13
- (2018) Rui-chao Li et al. Cell Death & Disease
- BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells
- (2018) Duc-Hiep Bach et al. Molecular Therapy-Nucleic Acids
- Circular RNA hsa_circ_0004015 regulates the proliferation, invasion, and TKI drug resistance of non-small cell lung cancer by miR-1183/PDPK1 signaling pathway
- (2018) You Zhou et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- MicroRNAs as a drug resistance mechanism to targeted therapies in EGFR-mutated NSCLC: Current implications and future directions
- (2018) Alessandro Leonetti et al. DRUG RESISTANCE UPDATES
- EGFR-Mutant Adenocarcinomas That Transform to Small-Cell Lung Cancer and Other Neuroendocrine Carcinomas: Clinical Outcomes
- (2018) Nicolas Marcoux et al. JOURNAL OF CLINICAL ONCOLOGY
- miR-608 and miR-4513 significantly contribute to the prognosis of lung adenocarcinoma treated with EGFR-TKIs
- (2018) Nasha Zhang et al. LABORATORY INVESTIGATION
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- MicroRNA therapeutics: towards a new era for the management of cancer and other diseases
- (2017) Rajesha Rupaimoole et al. NATURE REVIEWS DRUG DISCOVERY
- miR-223 reverses the resistance of EGFR-TKIs through IGF1R/PI3K/Akt signaling pathway
- (2016) JING HAN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- MET Exon 14 Mutations in Non–Small-Cell Lung Cancer Are Associated With Advanced Age and Stage-Dependent MET Genomic Amplification and c-Met Overexpression
- (2016) Mark M. Awad et al. JOURNAL OF CLINICAL ONCOLOGY
- The Biogenesis of Nascent Circular RNAs
- (2016) Yang Zhang et al. Cell Reports
- MiR-30a-5p Overexpression May Overcome EGFR-Inhibitor Resistance through Regulating PI3K/AKT Signaling Pathway in Non-small Cell Lung Cancer Cell Lines
- (2016) Fei Meng et al. Frontiers in Genetics
- Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation
- (2015) Shuhang Wang et al. Journal of Hematology & Oncology
- The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression
- (2015) Siyuan Dong et al. Journal of Hematology & Oncology
- Targeting RAS–ERK signalling in cancer: promises and challenges
- (2014) Ahmed A. Samatar et al. NATURE REVIEWS DRUG DISCOVERY
- MiR-21 overexpression is associated with acquired resistance of EGFR-TKI in non-small cell lung cancer
- (2013) Bing Li et al. LUNG CANCER
- Evolution and Functions of Long Noncoding RNAs
- (2009) Chris P. Ponting et al. CELL
- Causes and consequences of microRNA dysregulation in cancer
- (2009) Carlo M. Croce NATURE REVIEWS GENETICS
- EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines
- (2008) G. J. Weiss et al. ANNALS OF ONCOLOGY
- Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7
- (2008) Rebecca J. Webster et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started